°¡Å縯´ëÇб³¼¿ï¼º¸ðº´¿ø °¡Å縯 À¯¹æ¾Ï ½ÉÆ÷Áö¾ö : 2019-02-16±³À°ÀÏÀÚ : 2019-02-16
±³À°Àå¼Ò : ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
°¡Å縯 À¯¹æ¾Ï ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : °¡Å縯´ëÇб³¼¿ï¼º¸ðº´¿ø
´ã´çÀÚ : À±Ã¤Çõ
¿¬¶ôó : 02-2267-2296
À̸ÞÀÏ :
aid@pentaid.com ±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 4 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 09:30~09:40 Welcome remarks (°¡Å縯´ëÇб³)
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 09:40~10:00 For locoregional recurrent disease (°¡Å縯´ëÇб³)
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 10:00~10:20 For oligometastatic disease (°¡Å縯´ëÇб³)
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 10:20~10:40 For extensive metastatic disease (°¡Å縯´ëÇб³)
Åä·Ð 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 10:40~10:50 Åä·Ð ()
ÈÞ½Ä 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 10:50~11:00 ÈÞ½Ä ()
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 11:00~11:20 Understanding the PARP pathway in breast cancer (°¡Å縯´ëÇб³)
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 11:20~11:40 Current status of PARP inhibitoris in breast cancer (°¡Å縯´ëÇб³)
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 11:40~12:00 Novel targets in TNBC (°¡Å縯´ëÇб³)
Åä·Ð 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 12:00~12:10 Åä·Ð ()
½Ä»ç 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 12:10~13:00 ½Ä»ç ()
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 13:00~13:20 Looking out for (°¡Å縯´ëÇб³)
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 13:20~13:40 How to start up your own basic research lab (Tips from the real world) (¼º±Õ°ü´ëÇб³)
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 13:40~14:00 Maintaining your research and laboratory (°¡Å縯´ëÇб³)
Åä·Ð 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 14:00~14:10 Åä·Ð ()
ÈÞ½Ä 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 14:10~14:20 ÈÞ½Ä ()
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 14:20~14:40 Being a researcher in Catholic University of Korea (°¡Å縯´ëÇб³)
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 14:40~15:00 Being a researcher in Yonsei University (¿¬¼¼´ëÇб³)
±³À°½Ã°£ 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 15:00~15:20 Let's become a researcher (°¡Å縯´ëÇб³)
Åä·Ð 02-16 ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç 15:20~15:30 Åä·Ð ()